• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用酸性乳膏治疗细菌性阴道病:乳酸凝胶与甲硝唑疗效比较

Treatment of bacterial vaginosis with an acid cream: a comparison between the effect of lactate-gel and metronidazole.

作者信息

Andersch B, Forssman L, Lincoln K, Torstensson P

出版信息

Gynecol Obstet Invest. 1986;21(1):19-25. doi: 10.1159/000298923.

DOI:10.1159/000298923
PMID:3485071
Abstract

Bacteriological isolation of anaerobes, Gardnerella and lactobacilli was carried out in a group of 62 women with the diagnosis bacterial vaginosis and 42 control women. Lactobacilli were the predominant organisms in the control group whereas anaerobes dominated the flora in bacterial vaginosis patients. Lactate-gel (pH 3.5, 5 ml) inserted into the vagina daily for 7 days is as effective as oral metronidazole, 500 mg twice daily for 7 days. The women in both groups became symptom-free and objectively improved. Anaerobes were significantly reduced (p less than 0.0001) in both groups after 1-week treatment but Gardnerella was not significantly reduced. As bacterial vaginosis is generally looked upon as a mild noninflammatory condition lactate-gel seems to be an ideal treatment for this disease.

摘要

对62名诊断为细菌性阴道病的女性和42名对照女性进行了厌氧菌、加德纳菌和乳酸杆菌的细菌学分离。乳酸杆菌是对照组中的主要微生物,而厌氧菌在细菌性阴道病患者的菌群中占主导地位。每天向阴道内插入乳酸凝胶(pH 3.5,5毫升),持续7天,其效果与口服甲硝唑(500毫克,每日两次,共7天)相同。两组女性均症状消失且客观上有所改善。治疗1周后,两组中的厌氧菌均显著减少(p<0.0001),但加德纳菌未显著减少。由于细菌性阴道病通常被视为一种轻度非炎症性疾病,乳酸凝胶似乎是治疗该病的理想方法。

相似文献

1
Treatment of bacterial vaginosis with an acid cream: a comparison between the effect of lactate-gel and metronidazole.使用酸性乳膏治疗细菌性阴道病:乳酸凝胶与甲硝唑疗效比较
Gynecol Obstet Invest. 1986;21(1):19-25. doi: 10.1159/000298923.
2
Comparison of oral and vaginal metronidazole therapy for nonspecific bacterial vaginosis.口服与阴道用甲硝唑治疗非特异性细菌性阴道病的比较。
Gynecol Obstet Invest. 1986;21(3):144-9. doi: 10.1159/000298944.
3
Influence of metronidazole treatment on the vaginal microbiological flora.
Scand J Infect Dis Suppl. 1983;40:91-4.
4
Single dose of ornidazole in the treatment of bacterial vaginosis.单剂量奥硝唑治疗细菌性阴道病
Ann Chir Gynaecol Suppl. 1987;202:94-6.
5
[Role of Gardnerella vaginalis and anaerobes. Etiology of nonspecific colpitis].
Fortschr Med. 1984 Mar 15;102(10):255-8.
6
Gardnerella vaginalis and anaerobic bacteria in the etiology of bacterial (nonspecific) vaginosis.阴道加德纳菌和厌氧菌在细菌性(非特异性)阴道炎病因学中的作用
Scand J Infect Dis Suppl. 1983;40:41-6.
7
In-vitro and in-vivo activity of metronidazole against Gardnerella vaginalis, Bacteroides spp. and Mobiluncus spp. in bacterial vaginosis.
J Antimicrob Chemother. 1985 Aug;16(2):189-97. doi: 10.1093/jac/16.2.189.
8
Anaerobic vaginosis: therapeutic and epidemiological aspects.
J Antimicrob Chemother. 1984 Nov;14(5):445-8.
9
Bacterial vaginosis.细菌性阴道病
West Indian Med J. 1989 Sep;38(3):126-32.
10
The treatment of Gardnerella vaginalis vaginosis: a randomized comparison of pivampicillin with metronidazole.
Ann Clin Res. 1985;17(2):76-80.

引用本文的文献

1
Effectiveness and tolerability of lactic acid vaginal gel compared to oral metronidazole in the treatment of acute symptomatic bacterial vaginosis: a multicenter, randomized-controlled, head-to-head pilot study.乳酸阴道凝胶与口服甲硝唑治疗急性症状性细菌性阴道病的有效性和耐受性比较:一项多中心、随机对照、直接比较的试点研究。
BMC Womens Health. 2025 Jan 6;25(1):7. doi: 10.1186/s12905-024-03513-1.
2
Intravaginal lactic acid gel versus oral metronidazole for treating women with recurrent bacterial vaginosis: the VITA randomised controlled trial.阴道内用乳酸凝胶与口服甲硝唑治疗复发性细菌性阴道病的妇女:VITA 随机对照试验。
BMC Womens Health. 2023 May 9;23(1):241. doi: 10.1186/s12905-023-02303-5.
3
Postbiotics and Their Health Modulatory Biomolecules.
后生元和它们的健康调节生物分子。
Biomolecules. 2022 Nov 4;12(11):1640. doi: 10.3390/biom12111640.
4
Vaginal treatment with lactic acid gel delays relapses in recurrent urinary tract infections: results from an open, multicentre observational study.阴道使用乳酸凝胶治疗可延缓复发性尿路感染的复发:一项开放、多中心观察性研究的结果。
Arch Gynecol Obstet. 2021 Aug;304(2):409-417. doi: 10.1007/s00404-021-06040-8. Epub 2021 Mar 27.
5
Lactic acid-containing products for bacterial vaginosis and their impact on the vaginal microbiota: A systematic review.用于细菌性阴道病的含乳酸产品及其对阴道微生物群的影响:一项系统评价。
PLoS One. 2021 Feb 11;16(2):e0246953. doi: 10.1371/journal.pone.0246953. eCollection 2021.
6
Non-antibiotic treatment of bacterial vaginosis-a systematic review.细菌性阴道病的非抗生素治疗:系统评价。
Arch Gynecol Obstet. 2021 Jan;303(1):37-45. doi: 10.1007/s00404-020-05821-x. Epub 2020 Oct 6.
7
Metronidazole versus lactic acid for treating bacterial vaginosis (VITA): protocol for a randomised controlled trial to assess the clinical and cost effectiveness of topical lactic acid gel for treating second and subsequent episodes of bacterial vaginosis.甲硝唑与乳酸治疗细菌性阴道病(VITA):一项随机对照试验方案,以评估局部用乳酸凝胶治疗细菌性阴道病复发(第二次及后续发作)的临床和成本效益。
Trials. 2019 Nov 27;20(1):648. doi: 10.1186/s13063-019-3731-7.
8
Interplay Between the Host, the Human Microbiome, and Drug Metabolism.宿主、人体微生物组与药物代谢之间的相互作用。
Hum Genomics. 2019 Jun 11;13(1):27. doi: 10.1186/s40246-019-0211-9.
9
Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal health.乳酸杆菌属作为生物标志物和能够促进阴道健康各个方面的因子。
Front Physiol. 2015 Mar 25;6:81. doi: 10.3389/fphys.2015.00081. eCollection 2015.
10
Vaginal concentrations of lactic acid potently inactivate HIV.阴道内的乳酸浓度能有效灭活 HIV。
J Antimicrob Chemother. 2013 Sep;68(9):2015-25. doi: 10.1093/jac/dkt156. Epub 2013 May 8.